Clinical features, genomic profiling, and outcomes of adult patients with unifocal Langerhans cell histiocytosis

[1] Emile JF(2016)Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages Blood 127 2672-2681

[2] Abla O(2018)Langerhans-cell histiocytosis N Engl J Med 379 856-868

[3] Fraitag S(2022)International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults Blood 139 2601-2621

[4] Allen CE(2013)Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years Pediatr Blood Cancer 60 175-184

[5] Merad M(2010)Recurrent BRAF mutations in Langerhans cell histiocytosis Blood 116 1919-1923

[6] McClain KL(2015)MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis Genes Chromosomes Cancer 54 361-368

[7] Goyal G(2022)Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis Leukemia 36 573-576

[8] Tazi A(2022)Clinical features and outcomes of non-pulmonary unifocal adult Langerhans cell histiocytosis Blood Cancer J 12 89-87

[9] Go RS(2010)WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview Pathologica 102 83-e238

[10] Haupt R(2020)Methotrexate and cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis: a single arm, single center, prospective phase 2 study Am J Hematol 95 E235-46

[1] Emile JF(2016)Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages Blood 127 2672-2681

[2] Abla O(2018)Langerhans-cell histiocytosis N Engl J Med 379 856-868

[3] Fraitag S(2022)International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults Blood 139 2601-2621

[4] Allen CE(2013)Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years Pediatr Blood Cancer 60 175-184

[5] Merad M(2010)Recurrent BRAF mutations in Langerhans cell histiocytosis Blood 116 1919-1923

[6] McClain KL(2015)MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis Genes Chromosomes Cancer 54 361-368

[7] Goyal G(2022)Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis Leukemia 36 573-576

[8] Tazi A(2022)Clinical features and outcomes of non-pulmonary unifocal adult Langerhans cell histiocytosis Blood Cancer J 12 89-87

[9] Go RS(2010)WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview Pathologica 102 83-e238

[10] Haupt R(2020)Methotrexate and cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis: a single arm, single center, prospective phase 2 study Am J Hematol 95 E235-46